Anti-ageing Medicine: Myths and Chancesvdf Hochschulverlag AG, 2008 - 304 páginas The 21st century technological development is revolutionizing medicine and health care, bringing new hopes to human suffering by offering cures and treatments which were unthinkable a few decades ago. This is where anti-ageing medicine finds its niche. Anti-ageing medicine aims at slowing, arresting, and reversing phenomena associated with ageing by merging biotechnological innovation and engineered solutions. Ideally, by means of the newest medical technology, the "body machinery" should be kept fit and at peak performance all life long. Early detection of age-related dysfunction should thus be "fixed" at any age with interventions such as metabolic fine tuning, enhancement, regeneration, restoration or replacement of "body parts" (i.e. organs, skin, bone or muscle). It covers a vast array of domains: from cell therapy to pharmaceutical interventions, from bio-surgery to aesthetic surgery, from human enhancement to fortified food, from smart housing and robots to toxic-free environments. Anti-ageing medicine holds promises but also significant risks and safety issues which are addressesd in this book. It presents the latest scientific evidence on what works or does not work. It also provides public policy recommendations to ensure the protection of consumers and their rights while encouraging research and development. This book is intended for academics, health professionals, business persons, consumers and policy-makers interested in the latest evidence and ethical issues about anti-ageing medicine. |
Dentro del libro
Resultados 1-5 de 14
Página 46
... Alzheimer's disease for whom no treatment yet exists , and whorequire comfort or palliative treatment and care ) . b ) Better and Healthy Ageing Model – ' Successful Ageing ' this more recent model stems from results of studies on ...
... Alzheimer's disease for whom no treatment yet exists , and whorequire comfort or palliative treatment and care ) . b ) Better and Healthy Ageing Model – ' Successful Ageing ' this more recent model stems from results of studies on ...
Página 58
... Alzheimer's disease in 2000 and there is hope for its final development and first clinical application around 2010 (Dubois, 2007). A review of recent longitudinal data on the possible association of different lifestyles with dementia ...
... Alzheimer's disease in 2000 and there is hope for its final development and first clinical application around 2010 (Dubois, 2007). A review of recent longitudinal data on the possible association of different lifestyles with dementia ...
Página 92
... diseases such as Parkinson's and Alzheimer's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis. For example, it may become possible to generate healthy heart muscle cells in ...
... diseases such as Parkinson's and Alzheimer's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis. For example, it may become possible to generate healthy heart muscle cells in ...
Página 99
... Alzheimer's diseases, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, rheum- atoid arthritis and chronic heart disease. It also holds promises in tissue engineering due to growing new organs for ...
... Alzheimer's diseases, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, rheum- atoid arthritis and chronic heart disease. It also holds promises in tissue engineering due to growing new organs for ...
Página 110
... diseases such as Alzheimer's disease or the Down Syndrome. As long as safety and lack of evidence remains, this latter ethical position will remain irrelevant. b) Predictive medicine holds different ethical questions: how and for what ...
... diseases such as Alzheimer's disease or the Down Syndrome. As long as safety and lack of evidence remains, this latter ethical position will remain irrelevant. b) Predictive medicine holds different ethical questions: how and for what ...
Términos y frases comunes
AAM market AAM products acid age-related ageing process Alzheimer’s disease anti-ageing interventions anti-ageing medicine anti-ageing research antioxidant benefits better ageing biogerontologists biological biomarkers body Botox botulinum toxin brain cancer centenarians chelation therapy clinical cognitive consumers cosmetic decline devices DHEA dietary supplements disability disease effects elderly enhancement ethical evidence expectancy function gene therapy genes genetic genomics geriatric groups healthy ageing human improve increase individual issues lifestyle live longevity maximum life span mental health mesotherapy metabolic muscle nutrition old age older persons patients perspective physical activity population potential practice practitioners prevention problems process of ageing programme promotion recommendations reliability theory risk factors robots scientific scientists social society specific statins stem cell strategies Stuckelberger studies successful ageing surgery Swiss Switzerland TA-SWISS testing testosterone Theory of Ageing therapy tissue treatment vitamin vitamin E women